Japan postpones decision on first iPS cell trial
This article was originally published in Scrip
Executive Summary
A review committee of Japan's ministry of health, labour and welfare has put off a decision on whether to approve the world's first clinical trial with a regenerative therapy based on induced pluripotent stem (iPS) cells.